UAB Sveikatingumo ir terapijos studija Finance - revenue, profit
UAB Sveikatingumo ir terapijos studija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataIndicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
74,173 |
37,087 |
5,162 |
4,885 |
2,443 |
6.84 |
6.59 |
57,475 |
65,317 |
49,097 |
73,695 |
2023 |
---|
10,309 |
9,725 |
7,853 |
-7,853 |
-7,408 |
-76.18 |
-76.18 |
49,622 |
68,880 |
40,971 |
77,531 |
2024 |
---|
0 |
0 |
28,790 |
-28,790 |
-28,790 |
- |
- |
28,154 |
43,022 |
0 |
71,227 |
Register and
explore Okredo data2024 |
---|
0 |
0 |
28,790 |
-28,790 |
-28,790 |
- |
- |
28,154 |
43,022 |
0 |
71,227 |
Register and
explore Okredo data2024
Turnover (€)
0 €-100 % *
Sales per employee (€)
0 €-100 % *
Profit before tax (€)
28,790 €267 % *
Net Profit (€)
-28,790 €-267 % *
Profit per employee (€)
-28,790 €-289 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
28,154 €-43 % *
Amounts Payable And Liabilities (€)
43,022 €-38 % *
Non-current Assets (€)
0 €-100 % *
CurrentAssets (€)
71,227 €-8 % *